Monitoring of Patients with Heart Failure

References

• Mair J., Hammerer‐lercher A., Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001; 39: 571–88
   PubMed Web of Science ®Google Scholar
• Hartman F., Packer M., Coats A. J. S., Fowler M. B., Krum H., Mohasci P., Rouleau J. L., Tend era M., Castaigne A., Trawinski J. NT‐proBNP in severe chronic heart failure: rationale, design, and preliminary results of the COPERNICUS NT‐proBNP substudy. Eur J Heart Fail 2004; 6: 343–50
   PubMedGoogle Scholar
• Yu C. M., Sanderson J. E. Plasma brain natriuretic peptide – an independent predictor of cardiovascular mortality in acute heart failure. Eur J Heart Fail 1999; 1: 59–65
   PubMed Web of Science ®Google Scholar
• Packer M. Should B‐type natriuretic peptide be measure droutinely to guide the diagnosis and management of chronic heart failure?. Circulation 2003; 108: 2950–3
   PubMed Web of Science ®Google Scholar
• Nieminen M. S., Böhm M., Cowie M. R., Drexler H., Filippatos G. S., Jondeau G., Hasin Y., Lopez‐sendon J., Mebazaa A., Metra M., Rhodes A., Swedberg K., for the Task Force on Acute Heart Failure of the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005; 26: 384–416
   PubMed Web of Science ®Google Scholar
• Remme W. J., Swedberg K., for the European Society of Cardiology Task Force for the Diagnosis and Treatment of Chronic Heart Failure. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527–60
   PubMed Web of Science ®Google Scholar
• Fraser C. G. Inherent biological variation and reference values. Clin Chem Lab Med 2004; 42: 758–64
   PubMed Web of Science ®Google Scholar
• Latini R., Masson S., Anand I., Salio M., Hester A., Judd D., Barlera S., Maggioni A. P., Tognoni G., Cohn J. N. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val‐HeFT. Eur Heart J 2004; 25: 292–9
   PubMed Web of Science ®Google Scholar
• Luchner A., Hengstenberg C., Löwel H., Trawinski J., Baumann M., Riegger G. A. J., Schunkert H., Holmer S. N‐terminal pro‐brain natriuretic peptide after myocardial infarction – A marker of cardio‐renal dysfunction. Hypertension 2002; 39: 99–104
   PubMed Web of Science ®Google Scholar
• Mccullough P. A., Duc P., Omland T., Mc cord J., Nowak R. M., Hollander J. E. BNP and renal function in the diagnosis of heart failure: an analysis from the breathing not properly multinational study. Am J Kidney Dis 2003; 41: 571–9
   PubMed Web of Science ®Google Scholar
• Wang T. J., Larson M. G., Levy D., Emelia B., Leip E., Wilson P., Vasan R. S. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109: 594–600
   PubMed Web of Science ®Google Scholar
• Mehra M. R., Uber P. A., Park M. H., Scott R. L., Ventura H. D., Harris B. C., Frohlich E. D. Obesity and suppressed BNP levels in heart failure. J Am Coll Cardiol 2004; 43: 1590–5
   PubMed Web of Science ®Google Scholar
• Levin E. R., Gardner D. G., Samson W. K. Natriuretic Peptides (review). New Engl J Med 1998; 339: 321–8
   PubMed Web of Science ®Google Scholar
• Sothern R. B., Vesely D. L., Kanabrocki E. L., Bremner F. W., Third J. L., Mccormick J. B., Dawson S., Ryan M. Circadian relationships between circulating atrial natriuretic peptides and serum sodium and chloride in healthy humans. Am J Nephrol 1996; 16: 462–70
   PubMedGoogle Scholar
• Wu A. H. B., Packer M., Smith A., Bijou R., Fink D., Mair J., Wallentin L., Johnston N., Feldcamp C. S., Haverstick D. M., Ahnardi C. E., Grant A., Despres N., Bluestein B., Ghani F. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B‐type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 2004; 50: 867–73
   PubMed Web of Science ®Google Scholar
• Yeo K. T. J., Wu A. H. B., Apple F. S., Kroll M. H., Christenson R. H., Lewandrowski K. B., Sedor F. A., Butch A. W. Multicenter evaluation of the Roche NT‐proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 2003; 338: 107–115
   PubMed Web of Science ®Google Scholar
• Jensen K. T., Carsens J., Ivarsen P., Pedersen E. B. A new fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997; 57: 529–40
   PubMed Web of Science ®Google Scholar
• Sayama H., Nakamura Y., Saito N., Kinoshita M. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal?. Coron Artery Dis 1999; 10: 537–40
   PubMed Web of Science ®Google Scholar
• Maffei S., Clerico A., Iervasi G., Nannipieri M., Del ry S., Giannessi D., Donato L. Circulating levels of cardiac natriuretic hormones measured in women during menstrual cycle. J Endocrinol Invest 1999; 22: 1–5
   PubMed Web of Science ®Google Scholar
• Rutherford A. J., Anderson J. V., Elder M. G., Bloom S. R. Release of atrial natriuretic peptide during pregnancy and immediate puerperium. Lancet 1987; I: 928–9
   Google Scholar
• Nelzi deril G. V., Tagnochetti T., Nauti A., Klersy C., Papalia A., Vadacca G., Moratti R., Merlini G. Biological variation of NT‐proBNP in healthy individuals. Clin Chem 2003; 49: 1554–5
   PubMedGoogle Scholar
• Wu A. H. B., Smith A., Wieczorek S., Mather J. F., Duncan B., White M., Mcgill C., Katten D., Heller G. Biologic variation for N‐terminal pro and B‐type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003; 92: 628–31
   PubMed Web of Science ®Google Scholar
• Bruins S., Fokkema M. R., Römer J. W. P., Dejongste M. J. L., Van der dijs F. P. L., Van den ouweland J. M. W., Muskiet F. A. J. High intraindividual variation of BNP and NT‐proBNP in patients with stable chronic heart failure. Clin Chem 2004; 50: 2052–8
   PubMed Web of Science ®Google Scholar
• Hammerer‐lercher A., Pölzl G., Falkensammer G., Ludwig W., Hügel H., Pachinger O., Puschendorf B., Mair J. B‐type natriuretic peptide and N‐terminal pro B‐type natriuretic peptide are comparably useful for disease monitoring in heart failure. Int J Cardiol, 2005 in press
   Google Scholar
• Anand I. S., Fisher L. D., Chiang Y. T., Latini R., Masson S., Maggioni A. P., Glazer R. D., Tognoni G., Cohn J. N. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsertan Heart Failure Trial (Val‐HeFT). Circulation 2003; 107: 1278–83
   PubMed Web of Science ®Google Scholar
• Friedl W., Mair J., Thomas S., Pichler M., Puschendorf B. Natriuretic peptides and cyclic guanosine 3′,5′‐monophosphate in asymptomatic and symptomatic left ventricular dysfunction. Heart 1996; 76: 129–36
   PubMedGoogle Scholar
• Krüger S., Graf J., Merx M. W., Stickel T., Kunz D., Hanrath P., Janssens U. Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure. Int J Cardiol 2004; 95: 49–54
   PubMed Web of Science ®Google Scholar
• Herrmann M., Scharhag J., Miclea M., Urhausen A., Herrmann W., Kindermann W. Post‐racekinetics of cardiac troponin T and I and NT‐proBNP in marathon runners. Clin Chem 2003; 49: 831–4
   PubMed Web of Science ®Google Scholar
• Boomsma F., Deinum J., Van den meiracker A. H. Relationship between natriuretic peptide concentrations in plasma and posture during blood sampling. Clin Chem 2001; 47: 963–5
   PubMedGoogle Scholar